| Literature DB >> 25546075 |
Valentina Russo1, Annunziata Mauro, Alessandra Martelli, Oriana Di Giacinto, Lisa Di Marcantonio, Delia Nardinocchi, Paolo Berardinelli, Barbara Barboni.
Abstract
Processes of development during fetal life profoundly transform tendons from a plastic tissue into a highly differentiated structure, characterised by a very low ability to regenerate after injury in adulthood. Sheep tendon is frequently used as a translational model to investigate cell-based regenerative approaches. However, in contrast to other species, analytical and comparative baseline studies on the normal developmental maturation of sheep tendons from fetal through to adult life are not currently available. Thus, a detailed morphological and biochemical study was designed to characterise tissue maturation during mid- (2 months of pregnancy: 14 cm of length) and late fetal (4 months: 40 cm of length) life, through to adulthood. The results confirm that ovine tendon morphology undergoes profound transformations during this period. Endotenon was more developed in fetal tendons than in adult tissues, and its cell phenotype changed through tendon maturation. Indeed, groups of large rounded cells laying on smaller and more compacted ones expressing osteocalcin, vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) were identified exclusively in fetal mid-stage tissues, and not in late fetal or adult tendons. VEGF, NGF as well as blood vessels and nerve fibers showed decreased expression during tendon development. Moreover, the endotenon of mid- and late fetuses contained identifiable cells that expressed several pluripotent stem cell markers [Telomerase Reverse Transcriptase (TERT), SRY Determining Region Y Box-2 (SOX2), Nanog Homeobox (NANOG) and Octamer Binding Transcription Factor-4A (OCT-4A)]. These cells were not identifiable in adult specimens. Ovine tendon development was also accompanied by morphological modifications to cell nuclei, and a progressive decrease in cellularity, proliferation index and expression of connexins 43 and 32. Tendon maturation was similarly characterised by modulation of several other gene expression profiles, including Collagen type I, Collagen type III, Scleraxis B, Tenomodulin, Trombospondin 4 and Osteocalcin. These gene profiles underwent a dramatic reduction in adult tissues. Transforming growth factor-β~1 expression (involved in collagen synthesis) underwent a similar decrease. In conclusion, these morphological studies carried out on sheep tendons at different stages of development and aging offer normal structural and molecular baseline data to allow accurate evaluation of data from subsequent interventional studies investigating tendon healing and regeneration in ovine experimental models.Entities:
Keywords: blood vessels; calcaneal tendon; connexins; extracellular matrix molecules; fetus; growth factors; nerve fibers; pluripotency stem cell markers
Mesh:
Substances:
Year: 2014 PMID: 25546075 PMCID: PMC4304568 DOI: 10.1111/joa.12269
Source DB: PubMed Journal: J Anat ISSN: 0021-8782 Impact factor: 2.610
Details of primary and secondary antibodies used for IHC
| Primary Abs (Company details) | Primary Ab dilutions | Secondary Abs (Company details) | Secondary Ab dilutions |
|---|---|---|---|
| Ki-67 (Dako Cytomation, Denmark) | 1 : 50 | Alexa Fluor 488 anti-mouse (Invitrogen, Paisley, UK) | 1 : 200 |
| Barboni et al. ( | |||
| Cx43 (Chemicon Int. Billrerica, MA, USA) | 1 : 200 | Alexa Fluor 488 anti-mouse (Invitrogen, Paisley, UK) | 1 : 500 |
| Barboni et al. ( | |||
| Cx32 (Chemicon Int. Billrerica, MA, USA) | 1 : 200 | Alexa Fluor 488 anti-mouse (Invitrogen, Paisley, UK) | 1 : 750 |
| Barboni et al. ( | |||
| COL1 (Chemicon Int. Billrerica, MA, USA) | 1 : 100 | Alexa Fluor 488 anti-mouse (Invitrogen, Paisley, UK) | 1 : 200 |
| Barboni et al. ( | |||
| COL3 (Chemicon Int. Billrerica, MA, USA) | 1 : 500 | Alexa Fluor 488 anti-mouse (Invitrogen, Paisley, UK) | 1 : 200 |
| Barboni et al. ( | |||
| TGF-β1 (Abcam, Cambridge, UK) | 1 : 100 | Alexa Fluor 488 anti-mouse (Invitrogen, Paisley, UK) | 1 : 200 |
| Barboni et al. ( | |||
| VWF (Dako Cytomation, Denmark) | 1 : 400 | Alexa Fluor 488 anti-rabbit (Invitrogen, Paisley, UK) | 1 : 200 |
| Barboni et al. ( | |||
| VEGF (Novus Biologicals, Littleton, CO, USA) | 1 : 10 | Alexa Fluor 488 anti-rabbit (Invitrogen, Paisley, UK) | 1 : 200 |
| Barboni et al. ( | |||
| NF200 (Sigma-Aldrich, St. Louis, MO, USA) | 1 : 500 | Alexa Fluor 488 anti-rabbit (Invitrogen, Paisley, UK) | 1 : 250 |
| Barboni et al. ( | |||
| NGF (Sigma-Aldrich, St. Louis, MO, USA) | 1 : 400 | Alexa Fluor 488 anti-rabbit (Invitrogen, Paisley, UK) | 1 : 250 |
| Barboni et al. ( | |||
| OCN (Abcam, Cambridge, UK) | 1 : 50 | Alexa Fluor 488 anti-mouse (Invitrogen, Paisley, UK) | 1 : 400 |
| Barboni et al. ( | |||
| TERT (Calbiochem, Gibbstown, NJ, USA) | 1 : 250 | Alexa Fluor 568 anti-rabbit (Invitrogen, Paisley, UK) | 1 : 250 |
| Russo et al. ( | |||
| SOX2 (Abcam, Cambridge, UK) | 1 : 200 | Alexa Fluor 488 anti-rabbit (Invitrogen, Paisley, UK) | 1 : 200 |
| Barboni et al. ( | |||
| NANOG (Millipore, Billerica, MA, USA) | 1 : 500 | Alexa Fluor 488 anti-rabbit (Invitrogen, Paisley, UK) | 1 : 200 |
| Barboni et al. ( |
Primary and secondary antibodies (Abs) were diluted in PBS supplemented with 1% BSA. Cx, connexin; NGF, nerve growth factor; NF200, neurofilament 200; TGF, transforming growth factor; VEGF, vascular endothelial growth factor.
Primer sequences used for RT-PCR
| Gene | Accession number | Primer sequence | Product size (bp) | PCR cycles |
|---|---|---|---|---|
| AF030943.1 | F: CCTGCACCACCAACTGCTTG | 224 | 40 | |
| Ovine | R: TTGAGCTCAGGGATGACCTTG | |||
| AF129287.1 | F: CGTGATCTGCGACGAACTTAA | 212 | 40 | |
| Ovine | R: GTCCAGGAAGTCCAGGTTGT | |||
| AY091605.1 | F: AAGGGCAGGGAACAACTTGAT | 355 | 40 | |
| Ovine | R: GTGGGCAAACTGCACAACATT | |||
| NM_001099948.1 | F: TGGTGAAGACCTTCACTTTCC | 352 | 40 | |
| Bos Taurus | R: TTAAACCCTCCCCAGCATGC | |||
| NM_001034728.1 | F: CCGCAGGTCTTTGACCTTCT | 231 | 40 | |
| Bos Taurus | R: CAGGTAACGGAGGATGGCTTT | |||
| XM_866422.2 | F: AACAGCGTGAACACGGCTTTC | 299 | 45 | |
| Bos Taurus | R: TTTCTCTGGTTGCTGAGGCAG | |||
| DQ418490.1 | F: AGACACCATGAGAACCCCCAT | 234 | 40 | |
| Ovine | R: TTGAGCTCACACACCTCCCT | |||
| FJ970651.1 | F: TGGATCTGCTTATTCAGGACAG | 209 | 40 | |
| Ovine | R: TGCTGGAGGCTGAGGTATTTC | |||
| X96997.1 | F: ACCAGAAGAACAGCCCGGAC | 264 | 45 | |
| Ovine | R: TCATGAGCGTCTTGGTTTTCCG | |||
| EU139125.1 | F: TTGTCCCCGCAGGTGTCTTG | 176 | 45 | |
| Ovine | R: TGACCGTGTTGGGCAGGTAG | |||
| NM_174580.1 | F: TATGACTTGTGTGGAGGGATG | 327 | 45 | |
| Bos Taurus | R: AAACAGAACCCCCAGGGTGA |
PCR, polymerase chain reaction.
Figure 1Representative micrographs of HE staining in analyzed tendons. (A) Fourteen-centimeter fetus (mid-pregnancy), (B) 40-cm fetus (late pregnancy) and (C) adult tendon. In fetal tendons (A, B), the endotenon (*) was more developed and thicker (especially in the mid stage fetus one), (A) than that observed in adult tissue (C). Tendon tissue proper (§) is indicated in fetal (A, B) and adult tendons (C). Scale bar: 50 μm.
Figure 2Representative micrographs of tenocyte nuclei morphology, cellularity and PI quantification in fetus and adult tendons. Thicker endotenon (*) and tendon tissue proper (§) are indicated in the images. (A) On the left panel are shown: cell nuclei (DAPI blue stain) morphology derived from fetuses of mid (a), late pregnancy (b) and adult tissues (c). In the box, details of tenocyte nuclei shapes in tendon tissue proper (§), scale bar: 25 μm. Ki-67, a cell proliferation marker, positive cells (green stained), in fetuses of mid (d), late pregnancy (e) and adult tissues (f). Cell nuclei were counterstained with DAPI (blue stain). Arrowheads and arrows indicate examples of Ki-67-positive cells in endotenon (*) and tendon tissue proper (§), respectively. Scale bar: 50 μm. (B) The histograms indicate cellularity in fetuses of mid, late pregnancy and adult tendons determined as the mean ± standard error (± SE) of the total number of DAPI-stained nuclei in the field. aSignificantly different values between fetuses (P < 0.05); bsignificantly different values of adult samples vs. both types of fetuses (P < 0.05). (C) The histograms show the PI of the analyzed tendons as mean ± SE of % Ki-67 green-stained cells/total number of nuclei in the field. aSignificantly different values between fetuses (P < 0.05); bsignificantly different values of adult samples vs. both types of fetuses (P < 0.05).
Figure 3Representative micrograph of Cx43 and Cx32 protein localisation (A), expression (B) and their quantification (C, D) in fetal and adult tendons. In the left panel (A), Cx43 (a–c) and Cx32 (d–f) protein expression (green stain) in the analyzed tendons is shown. The cell nuclei were counterstained with DAPI (blue stain). The tendons were isolated from fetuses of mid (a, d), late (b, e) pregnancy and adult (c, f) tissues. Endotenon (*) and tendon tissue proper (§) are indicated in the images. Scale bar: 50 μm. On the right panel (B), representative images of Cx43 and Cx32 protein expression analyzed by Western blot; the arrow indicates the phosphorylated form of Cx43 protein. Histograms show densitometric values of Cx43 (C) and Cx32 (D) protein expression normalised for α-tubulin expression. The values are expressed as the mean of three independent experiments ± SE for each sample. aSignificantly different values of adult samples vs. both types of fetuses (P < 0.05).
Figure 4(A) Representative images of COL1, COL3, TNMD, THBS4, SCXB and OCN mRNA gene expression profile by RT-PCR in mid and late fetal, and adult tendons. (B) The histograms indicate a semi-quantitative analysis of gene expression normalised for GAPDH. Each value was expressed as the mean of three replicates ± SE for each sample. aSignificantly different values between fetuses (P < 0.05); bsignificantly different values of adult samples vs. both types of fetuses (P < 0.05).
Figure 5Representative micrographs of OCN, COL1 and COL3 immunostaining in mid (A, D, G) and late (B, E, H) fetal, and adult (C, F, I) tendons. Endotenon (*) and tendon tissue proper (§) are indicated in the images. On the left images (A–C), OCN-positive cells (green stain), with large rounded (arrowhead) or smaller compacted (arrow) morphology, are localised in tendons. Scale bar: 25 μm. The middle (D–F) and the right (G–I) images show COL1 and COL3 proteins (green stain), respectively, in the analyzed tendons. Cell nuclei were counterstained with DAPI (blue stain). Scale bar: 25 μm.
Figure 6Representative micrographs of TGF-β1 immunostaining (A) and its quantification (B) in the analyzed tendons. Endotenon (*) and tendon tissue proper (§) are indicated in the images. (A) The images of (a) 14-cm fetuses, (b) 40-cm fetuses and (c) adult tendons show how TGF-β1 was always recorded within the endotenon in the ECM during tendon development. Scale bar: 50 μm. (B) The histograms show the quantitative analysis of TGF-β1-positive area in μm2 field expressed as mean ± SE. aSignificantly different values between fetuses (P < 0.05); bsignificantly different values of adult samples vs. both types of fetuses (P < 0.05).
Figure 7Representative micrographs of vWF and VEGF immunostaining (A, B) in the analyzed tendons and their quantification (C, D). (A) On the left images (a–c), vWF (green stain), an endothelial marker, is shown. On the right images (d–f), VEGF protein (green stain) is localised in the analyzed tendons. Tendons were isolated in fetuses of mid (a, d, B), late (b, e) pregnancy and adults (c, f). Endotenon (*) and tendon tissue proper (§) are indicated in the images. Scale bar: 50 μm. (B) vWF (green stain) and VEGF protein (red stain) distribution within the endotenon visualised using a double-immunostaining. VEGF-secreting cells (arrowed) are closely positioned to vWF endothelial cells (arrow) of blood vessels. Cell nuclei were counterstained with DAPI (blue stain). Scale bar: 25 μm. (C) The histograms show the VA in fetuses of mid- and late pregnancy and adult tendons determined as the mean ± SE of vWF-positive area in μm2 field. aSignificantly different values between fetuses (P < 0.05); bsignificantly different values of adult samples vs. both types of fetuses (P < 0.05). (D) The histograms show VEGF-positive area in μm2 field expressed as mean ± SE. aSignificantly different values between fetuses (P < 0.05); bsignificantly different values of adult samples vs. both types of fetuses (P < 0.05).
Figure 8Representative micrographs of NF200 and NGF protein expression (A) and their quantification in fetal and adult tendons (B, C). The tendons were isolated from fetuses of mid- (a, d) and late (b, e) pregnancy and adults (c, f). Endotenon (*) and tendon tissue proper (§) are indicated in the images. (A) On the left images (a–c), NGF protein (green stain) localised in the analyzed tendons is showed. Examples of round NGF-positive cells (arrow) are indicated in endotenon. The right images (d–f) show NF200 protein (green stain) in the analyzed tendons. Example of neurofilaments (arrow) are indicated in the images. Cell nuclei were counterstained with DAPI (blue stain). Scale bar: 50 μm. (B, C) Histograms show quantitative analyses of (B) NGF- or (C) NF200-positive area in μm2 field expressed as mean ± SE. aSignificantly different values between fetuses (P < 0.05); bsignificantly different values of adult samples vs. both types of fetuses (P < 0.05).
Figure 9(A) Representative images of TERT, SOX2, NANOG and OCT-4A mRNA stemness-related gene expression profile by RT-PCR in 14-cm fetuses, 40-cm fetuses and adult tendons. (B) The histograms indicate a semi-quantitative analysis of gene expression normalised for GAPDH. Each value was expressed as the mean of three replicates ± SE for each sample. aSignificantly different values between fetuses (P < 0.05); bsignificantly different values of adult samples vs. both types of fetuses (P < 0.05).

Representative micrographs of immunostaining for TERT, SOX2 and NANOG in mid (A, D and G), late (B, E and H) fetal, and adult tendons (C, F and I). In adult tendons no immunoreactivity to these markers was present. Endotenon (*) and tendon tissue proper (§) are indicated in the images. All these pluripotency stemness markers were always localised within the endotenon (*). On the left images (A, B), TERT localisation (red stain) in the analyzed tendons is shown. The middle images (D, E) show SOX2 distribution (green stain) and, on the right images (G, H), NANOG protein (green stain) expression is also assessed. Examples of nuclei (arrowhead) or cytoplasm (arrow) positive cells are indicated for each marker in the images. Cell nuclei were counterstained with DAPI (blue stain). Scale bar: 50 μm.